2017 tallies 189 IPOs, a 61 percent increase over 2016

By John Filar AtwoodDespite a slow December, the IPO market turned in a solid performance in 2017. The 189 deals represented a 61 percent improvement on the 117 new issues completed in 2016. It was also slightly better than 2015’s 185 IPOs, and 2017’s aggregate offering proceeds of $44 billion far exceeded 2015’s $33 billion. No companies went public in the final week of the year, leaving December with 11 completed deals, a significant drop from November’s 28 offerings.New registrants. Although no IPOs were completed, the week’s activity did include seven new registrations. Three pharmaceutical preparations companies—Menlo Therapeutics, ARMO BioSciences and resTORbio—registered last week. Menlo Therapeutics is developing a treatment for the itch associated with numerous dermatological conditions, while ARMO BioSciences is creating products to treat cancer. Boston-based resTORbio is working on therapeutics to treat aging-related…

Read more detail on Recent Banking and Finance Law posts –

This entry was posted in Banking and Finance law and tagged , , , , , , . Bookmark the permalink.

Leave a Reply